Epithelial Na+ channel inhibitors for the treatment of cystic fibrosis

Pharmaceutical patent analyst

Volumn 6, Issue 4, 2017, Pages 179-188

  Smith, Nichola J ^a   Solovay, Catherine F ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

cystic fibrosis transmembrane conductance regulator; epithelial Na+ channel; mucociliary clearance

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL; EPITHELIAL SODIUM CHANNEL BLOCKING AGENT;

CYSTIC FIBROSIS; HUMAN; MUCOCILIARY CLEARANCE;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL BLOCKERS; EPITHELIAL SODIUM CHANNELS; HUMANS; MUCOCILIARY CLEARANCE;

EID: 85054859347     PISSN: None     EISSN: 20468962     Source Type: Journal    
DOI: 10.4155/ppa-2017-0009     Document Type: Article

References (0)